News

Nova Minerals Limited ("Nova" or the "Company") (NASDAQ: NVA) (ASX: NVA) (FRA: QM3)) is pleased to announced that the Alaska ...
Paving the Way for Broader Access and the First Combined CCM®/ICD SystemMARLTON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the l ...
TransDigm Group Incorporated (NYSE: TDG) today said it will report fiscal 2025 third quarter earnings before the market opens on Tuesday, August 5, 2025. A ...
Strategic partnership provides multi-location QSRs and enterprise restaurants with flexible payment technology to enhance omnichannel capabilities and simplify operationsPhiladelphia, PA, July 28, 202 ...
Breakthrough Achieved in Collaboration with Daikin America, Inc. Marks Major Step Toward Scalable, Cost-Effective PFAS Elimination MINNEAPOLIS, July 28, 2025 /PRNewswire/ -- Claros is pleased ...
Analysis of first-in-class CNS-101 study validates that at-home endpoints showed greater separation with Alzheimer's pathology (pTau217) than the benchmark endpoint Alzheimer's Disease Assessment ...
Integration Bridges the Gap Between Manual Processes and Data Entry Into ERP Systems, Cutting Turnaround Times for Aviation Suppliers MIAMI, FLORIDA / ACCESS Newswire / July 28, 2025 / When aircraft s ...
DELRAY BEACH, FL / ACCESS Newswire / July 28, 2025 / Headwall Partners LLC ("Headwall"), an independent investment banking firm focused exclusively on the steel, metals, and mining industries, is plea ...
Proposed Merger of Regional Health Properties, Inc. ("Regional" or "the Company") with SunLink Health Systems, Inc. ("SunLink").The Company is trying to hide three superior offers from you in order to ...
Clear Start Tax warns surviving spouses about tax liens, joint return risks, and surprise benefit garnishments. IRVINE, CA / ACCESS Newswire / July 28, 2025 / For ...
MIAMI BEACH, FL / ACCESS Newswire / July 28, 2025 / C2 Blockchain Inc. (OTC:CBLO), a publicly traded company specializing in blockchain infrastructure and digital asset treasury strategies, today anno ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe and well-tolerated in healthy elderly volunteers, showing a favourable ph ...